Pfizer Inc (PFE)
25.63
+0.50
(+1.99%)
USD |
NYSE |
Nov 22, 16:00
25.60
-0.03
(-0.12%)
After-Hours: 20:00
Pfizer Cash from Operations (Quarterly): 6.714B for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.714B |
| June 30, 2024 | -1.781B |
| March 31, 2024 | 1.09B |
| December 31, 2023 | 5.24B |
| September 30, 2023 | 3.456B |
| June 30, 2023 | -1.208B |
| March 31, 2023 | 1.212B |
| December 31, 2022 | 8.582B |
| September 30, 2022 | 5.974B |
| June 30, 2022 | 8.17B |
| March 31, 2022 | 6.541B |
| December 31, 2021 | 5.914B |
| September 30, 2021 | 10.83B |
| June 30, 2021 | 11.30B |
| March 31, 2021 | 4.538B |
| December 31, 2020 | 5.625B |
| September 30, 2020 | 2.09B |
| June 30, 2020 | 3.555B |
| March 31, 2020 | 3.133B |
| December 31, 2019 | 3.769B |
| September 30, 2019 | 4.51B |
| June 30, 2019 | 2.611B |
| March 31, 2019 | 1.698B |
| December 31, 2018 | 4.738B |
| September 30, 2018 | 5.259B |
| Date | Value |
|---|---|
| June 30, 2018 | 3.847B |
| March 31, 2018 | 1.983B |
| December 31, 2017 | 7.089B |
| September 30, 2017 | 4.889B |
| June 30, 2017 | 3.24B |
| March 31, 2017 | 1.584B |
| December 31, 2016 | 6.041B |
| September 30, 2016 | 4.737B |
| June 30, 2016 | 3.606B |
| March 31, 2016 | 1.808B |
| December 31, 2015 | 4.898B |
| September 30, 2015 | 5.02B |
| June 30, 2015 | 4.09B |
| March 31, 2015 | 680.00M |
| December 31, 2014 | 5.599B |
| September 30, 2014 | 4.463B |
| June 30, 2014 | 4.087B |
| March 31, 2014 | 2.935B |
| December 31, 2013 | 5.724B |
| September 30, 2013 | 5.90B |
| June 30, 2013 | 3.757B |
| March 31, 2013 | 2.303B |
| December 31, 2012 | 4.948B |
| September 30, 2012 | 5.003B |
| June 30, 2012 | 4.021B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-1.781B
Minimum
Jun 2024
11.30B
Maximum
Jun 2021
4.737B
Average
4.889B
Median
Cash from Operations (Quarterly) Benchmarks
| Amgen Inc | 3.571B |
| Johnson & Johnson | 7.993B |
| Eli Lilly and Co | 3.712B |
| Merck & Co Inc | 9.291B |
| Moderna Inc | -1.566B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.057B |
| Cash from Financing (Quarterly) | -4.636B |
| Free Cash Flow | 8.227B |
| Free Cash Flow Per Share (Quarterly) | 1.063 |
| Free Cash Flow to Equity (Quarterly) | 8.123B |
| Free Cash Flow to Firm (Quarterly) | 6.697B |
| Free Cash Flow Yield | 5.65% |